Kempharm, INC.
Pharmaceutical company engaged in the discovery and development of proprietary prodrugs
Based in IA
🤖
AI Overview
With $70K in lobbying spend across 3 quarterly filings, Kempharm, INC is an active lobbying client. Their lobbying covers 2 issue areas.
$70K
Total Spend
1
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
- •Prodrug therapies and improving abuse deterrence and consumer safety
- •Anti-opioid abuse deterrent legislation
- •FDA regulation of opioid abuse deterrent formulations
- •Prodrug therapies and improving abuse deterrence and consumer safety
- •Anti-opioid abuse deterrent legislation
- •H.R. 6 (SUPPORT for Patients and Communities Act), provisions relating to HHS study on abu
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.